Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cinchonine is a naturally occurring **alkaloid** found primarily in the bark of *Cinchona* species such as *Cinchona officinalis*[3][6]. Historically, it was used as an **antimalarial agent** due to its ability to inhibit heme polymerase within the malaria parasite, Plasmodium, disrupting the parasite's detoxification process and leading to its death[1]. Its pharmacological properties include **anti-inflammatory**, **analgesic**, **antipyretic**, **antioxidant**, and **antiarrhythmic effects**; these are attributed to its action on ion channels, inhibition of inflammatory mediator synthesis, and modulation of neurotransmitter systems[1]. In addition to medical uses, cinchonine serves as a crucial **chiral catalyst** in asymmetric synthesis within organic chemistry, enabling the production of enantiomerically pure compounds[3][4]. Structurally, cinchonine is a stereoisomer and pseudo-enantiomer of cinchonidine[3][6], with molecular formula C19H22N2O. Its primary indications are antimalarial and, to a lesser extent, analgesic and anti-inflammatory uses. It is mostly supplanted by more potent antimalarials but remains relevant for chemical synthesis and research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cinchonine.